Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma

Conditions:   CD38 Positive;   Plasma Cell Myeloma Interventions:   Biological: Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10;   Drug: Melphalan;   Procedure: Peripheral Blood Stem Cell Transplantation Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI);   National Institutes of Health (NIH) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials